PMDA drug package insert
アムヴトラ皮下注25mgシリンジ
PMDA Prescription drug · Alnylam Japan株式会社 · package insert Jun 24, 2025
Key facts
| Brand names | アムヴトラ皮下注25mgシリンジ |
|---|---|
| Nonproprietary names | ブトリシランナトリウム |
| Companies | 製造販売元／Alnylam Japan株式会社 |
| Product type | Prescription drug |
| Therapeutic category | トランスサイレチン型アミロイドーシス治療薬 |
| Therapeutic category codes | 87129, 87219 |
| YJ codes | 1290401G1021 |
| Approval numbers | 30400AMX00432000 |
| Package insert edition | 第2版 |
| Package insert date | Jun 24, 2025 |
| PMDA document key | 112773_1290401G1021_1 |
| PMDA company code | 112773 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: